Licensing, research and development agreement for anti-HF antibody AV-299Licensing, Research and Development Agreement • September 23rd, 2022 • New York
Contract Type FiledSeptember 23rd, 2022 JurisdictionUnder the terms of the agreement, human dosing with SCH900105 (AV-299) triggers a $3.0 million milestone payment from Schering Plough to AVEO.
Licensing, research and development agreement for anti-HF antibody AV-299Licensing, Research and Development Agreement • September 23rd, 2022 • New York
Contract Type FiledSeptember 23rd, 2022 JurisdictionUnder the terms of the agreement, human dosing with SCH900105 (AV-299) triggers a $3.0 million milestone payment from Schering Plough to AVEO.